Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 4Lymphoma 4Hodgkin Disease 4Prostatic Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Congenital Abnormalities 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Immunoblastic Lymphadenopathy 2Colorectal Neoplasms 2Colonic Neoplasms 2

Interventions

Pharmacogenomic Testing 2bempegaldesleukin 1Sorafenib 1Polymerase Chain Reaction 1Nutritionists 1HhAntag691 1Fluorouracil 1Chromatography, High Pressure Liquid 1Celecoxib 1Capecitabine 1Base Sequence 1Amplified Fragment Length Polymorphism Analysis 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Unspecified Adult Solid Tumor, Protocol Specific × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01206465 2023-12-26

Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors

University of Nebraska

Phase 1 Completed
29 enrolled 12 charts
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡